Exercise Therapy Added to First-line Chemotherapy for Ovarian Cancer: Effects on Progression-free Survival and Physical Wellbeing in the Randomised, Phase 3 Echo Trial (anzgog1304/ctc121)
Year: 2025
Type: article
Study design: Clinical Trial
Authors: Sandra Hayes, Andreas Obermair, Rosa Spence, Linda Mileshkin, Alison Davis, Alison Brand, Elizabeth Barnes, Louisa Collins, John Andrews, Monika Janda, Dimitrios Vagenas, Diana Adams, Yeh Chen Lee, Vanessa Beesley, Penelope Webb, Michael Friedlander, Helene O’Neille, Merran Williams, Trudi Cattley, Sara Baniahmadi, James Nicklin, Andrea Garrett, Piksi Singh, Jeff Goh, Catherine Shannon, Lewis Perrin, Marcelo Nascimento, Philip Beale, Amasy Alkhateeb, Dirkje Sommeijer, Tamara Jones, Melissa Creed, Sheree Rye, Carolina Sandler, Kate Pumpa, Martin Stockler
Institutions: The University of Sydney, The University of Queensland, Cancer Council Queensland, Queensland University of Technology, Peter MacCallum Cancer Centre, Australian National University, Canberra Hospital, Westmead Hospital, QIMR Berghofer Medical Research Institute, Australia New Zealand Gynaecological Oncology Group, National Health and Medical Research Council, GenesisCare, UNSW Sydney
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4416019279